Master Finmagine's US stock analysis through video tutorial, audio deep dive, comprehensive overview, and interactive knowledge testing
This comprehensive tutorial covers every feature of the Finmagine Chrome Extension for US stock analysis on stockanalysis.com. From the 10-page parallel data fetch architecture to sector-weighted valuation verdicts, you will learn how to perform institutional-grade equity research in under five minutes per stock—entirely free, entirely in your browser, with zero data collection.
Follow along with this comprehensive video demonstration of Finmagine's US stock analysis features in action on stockanalysis.com.
Video Title: Five-Minute Institutional Stock Analysis (FREE Tool) | Finmagine v2.3.0 Deep Dive
Complete video demonstration with real US stock examples and live analysis walkthrough
Prefer to listen? This complete audio walkthrough covers every tab, every metric, and every sector-specific strategy for US stock analysis.
Duration: Full tutorial | Format: Professional narration
Deep dive audio guide exploring institutional-grade US stock analysis techniques and sector-aware analytical best practices
Click any flashcard to reveal the answer. Use the search box to find specific topics. 70 cards covering every aspect of US stock analysis with Finmagine.
stockanalysis.com is one of the most data-rich free platforms for US equity research. It provides income statements, balance sheets, cash flow statements, financial ratios, statistics, analyst forecasts, and historical price data for thousands of US-listed companies. But that data is spread across ten separate pages, each requiring manual navigation, mental arithmetic, and the cognitive burden of converting raw numbers into investment insights.
The Finmagine Financial Chart Builder transforms that fragmented experience into a unified, institutional-grade analysis panel that sits directly on top of stockanalysis.com. No new tabs. No exports to Excel. No subscription. No data collection. Everything runs in your browser.
The extension is free forever—no trial, no premium tier, no account creation required.
stockanalysis.com/stocks/aapl/)
The golden “Visualize with Finmagine” button and notification toast on Alphabet’s stockanalysis.com page
The extension’s manifest declares content scripts for *://stockanalysis.com/stocks/*. When you land on any stock page, the content script activates and injects the floating button.
stockanalysis.com is built with Next.js, which uses client-side navigation (Single Page Application architecture). This means clicking from Apple to Microsoft does not trigger a full page reload—the URL changes silently via history.pushState.
The extension handles this with a URL polling mechanism that checks the current URL every 1.5 seconds. When it detects a stock change, it automatically:
When you click the golden button, a full-height panel slides in from the right side of the page. This is your complete analysis workspace. Let us walk through every element.
The header bar at the top of the panel contains:
The right side of the header contains five control buttons in this exact order:
/stocks/aapl/ becomes AAPL)localStorage and persists across sessionsBelow the header, five horizontally arranged tabs provide access to the complete analysis suite:
| Tab | Icon | Purpose | Default |
|---|---|---|---|
| Charts | Line chart | Visualize financial trends with interactive dual-axis charts | Active on open |
| Quick Analysis | Pie chart | Health Score, sector intelligence, financial models, analyst data | — |
| Calculated Ratios | Shield | DuPont Analysis, 40+ color-coded financial ratios | — |
| Price Analysis | Trending line | Price vs. fundamentals, risk metrics, market position | — |
| Valuation | Table + “NEW” badge | Sector-weighted valuation verdict vs. 5-year history | — |
When you click “Visualize with Finmagine” on a US stock, the extension initiates a sophisticated multi-phase data extraction pipeline entirely within your browser. This is the engine that powers every tab.
These five pages are fetched first in staggered batches of three, with 400ms delays between batches to avoid rate limiting:
| Page | URL Pattern | Data Extracted |
|---|---|---|
| Income Statement | /stocks/{SYMBOL}/financials/ |
Revenue, Net Income, EPS, EBITDA, Margins (5 years) |
| Balance Sheet | /financials/balance-sheet/ |
Total Assets, Liabilities, Equity, Debt, Working Capital |
| Cash Flow | /financials/cash-flow-statement/ |
Operating CF, CapEx, Free Cash Flow, Financing Activities |
| Ratios | /financials/ratios/ |
PE, P/B, EV/EBITDA, ROE, ROA, Annual Margins |
| Profile | /stocks/{SYMBOL}/company/ |
Sector, Industry (for sector detection), Company Description |
The UI renders immediately after Phase 1 completes—you see the Charts and Quick Analysis tabs within seconds.
While you are already exploring the panel, these additional pages load in the background:
| Page | URL Pattern | Data Extracted |
|---|---|---|
| Quarterly Income | /financials/?p=quarterly |
Recent quarterly revenue, profit, EPS trends |
| Quarterly Balance Sheet | /financials/balance-sheet/?p=quarterly |
Recent quarterly asset/liability changes |
| Quarterly Cash Flow | /financials/cash-flow-statement/?p=quarterly |
Recent quarterly cash generation patterns |
| Statistics | /stocks/{SYMBOL}/statistics/ |
50+ current metrics: valuations, scores, analyst forecasts, ownership, technicals |
| History | /stocks/{SYMBOL}/history/ |
Daily OHLCV price data for 52-week calculations |
When Phase 2 completes, the Quick Analysis and Price Analysis tabs automatically refresh to include the enriched data (Financial Scores, Market Position, etc.).
729.00M, 5.90B, 25.3%, negative values with dashes, and blank cells.The Charts tab is the default view when you open the panel. It presents all extracted financial data as interactive tables with checkboxes, allowing you to build custom visualizations by selecting any combination of metrics.
Live example: Alphabet (GOOGL) — Revenue & EBITDA bars with FCF & Operating Margin lines. Note the hover tooltip, interactive legend, and metric checkboxes below.
Every financial metric in every table section has a checkbox next to it. Click any checkbox to instantly add that metric to the chart—no “Generate” or “Submit” button required. The chart updates in real time with smooth animations.
Each table section has a “Select All” checkbox in its header row. Click it to add every metric from that section to the chart simultaneously. Click again to deselect all.
The chart uses Chart.js to render a mixed bar-and-line visualization with two Y-axes:
localStorageHovering over any bar or line point triggers a dark-themed tooltip (#1a1f29 background) showing:
The extension automatically saves your selected metrics to localStorage (keyed per site). When you revisit the same stock or navigate to a different stock on stockanalysis.com, your metric selections are automatically restored. This means if you always analyze Revenue + Net Income + FCF + Operating Margin, you never have to re-select them.
The chart uses a rotating 10-color palette to distinguish metrics: Blue (#4A90E2), Red (#E94B3C), Green (#6FDC8C), Orange, Purple, Cyan, Yellow, Pink, Teal, and Coral. If you select more than 10 metrics, colors repeat.
For any stock analysis, start with these four metrics to get the story in under 60 seconds:
The extension parses and displays values using standard financial notation:
A small “Powered by Finmagine” watermark appears in the bottom-right corner of the chart. It is clickable and opens finmagine.com in a new tab. This adds credibility when sharing chart screenshots.
The Quick Analysis tab is the flagship feature of the extension. It synthesizes data from all 10 fetched pages into a single-screen health assessment that takes seconds to read but would take a human analyst 30+ minutes to compile manually.
Live example: Amazon (AMZN) — Health Score 93 (Excellent), key metrics grid with 8 indicators, Strengths & Concerns, and Quarterly Trend Analysis
At the top-left of the tab, a large circular SVG gauge displays the company’s overall health score:
| Score Range | Rating | Color | Interpretation |
|---|---|---|---|
| 70–100 | Excellent | Green | Strong fundamentals. Proceed to valuation to check if price is reasonable. |
| 50–69 | Good | Orange | Mixed signals. Investigate the specific concerns before making investment decisions. |
| Below 50 | Fair/Poor | Red | Weak fundamentals. Only consider as turnaround plays with a clear catalyst thesis. |
The score is a weighted average across five categories:
For each category, the engine counts strengths vs. concerns against sector-specific thresholds, then computes: (positive points × 100) / max possible points.
The extension reads the company’s GICS Industry from the Profile page and maps it to one of 19 analysis profiles using a comprehensive 145+ industry mapping table. This is not a simple sector lookup—it checks the specific industry first (exact match), then falls back to the broad sector if no industry match is found.
To the right of the Health Score, a grid displays up to 8 contextual metrics based on the detected sector:
| Metric | Shown For | What It Tells You |
|---|---|---|
| ROE | All sectors | Return on Equity — how efficiently the company uses shareholders’ capital |
| ROCE | All sectors | Return on Capital Employed — includes debt in the denominator |
| OPM | All sectors | Operating Profit Margin — core business profitability |
| ROIC | US stocks | Return on Invested Capital — the “truth” of capital allocation |
| Beta | US stocks | 5-year volatility relative to S&P 500 |
| F-Score | US stocks | Piotroski F-Score (out of 9) — financial strength |
| Z-Score | US stocks | Altman Z-Score — bankruptcy risk prediction |
| D/E | Non-banking | Debt to Equity ratio — financial leverage |
Each metric card shows the value, and a trend indicator arrow (up, down, or stable).
Below the Health Score, two columns list specific findings:
Each item shows the metric name, a description, and the actual value.
A dedicated section shows Compound Annual Growth Rates across four time horizons:
For each period: Revenue CAGR, Profit CAGR, and EPS CAGR. Color-coded: green for 15%+ growth, orange for 5–15%, red for below 5%.
The right column shows three types of trend analysis:
For Indian stocks, the right column shows Shareholding Movement (Promoter, FII, Pledging). For US stocks, this is replaced by three institutional-grade panels:
Amazon (AMZN) — Growth CAGR across all horizons, Financial Scores (Z-Score 5.06 Safe, F-Score 5/9, ROIC-WACC +3.2%), and Analyst Consensus
Developed by Professor Edward Altman in 1968, this formula combines five financial ratios into a single score that predicts bankruptcy probability:
Z = 1.2×(Working Capital/Total Assets) + 1.4×(Retained Earnings/Total Assets) + 3.3×(EBIT/Total Assets) + 0.6×(Market Cap/Total Liabilities) + 1.0×(Revenue/Total Assets)
| Z-Score | Zone | Color | Interpretation |
|---|---|---|---|
| > 2.99 | Safe Zone | Green | Low probability of bankruptcy. Healthy balance sheet. |
| 1.81 – 2.99 | Grey Zone | Orange | Uncertain. Elevated risk requiring further investigation. |
| < 1.81 | Distress Zone | Red | High probability of bankruptcy. Major red flag. |
Developed by Joseph Piotroski in 2000, this score awards one point for each of nine binary criteria across three categories:
| Category | Criterion | Pass Condition |
|---|---|---|
| Profitability (3 points) | Net Income | Positive |
| Operating Cash Flow | Positive | |
| ROA Trend | Improved year-over-year | |
| Leverage (3 points) | Debt Trend | Long-term debt decreased |
| Current Ratio Trend | Improved | |
| Share Dilution | No new shares issued | |
| Efficiency (3 points) | Gross Margin Trend | Improved |
| Asset Turnover Trend | Improved | |
| Cash Flow Quality | Operating CF > Net Income |
| Score | Rating | Color | Investment Implication |
|---|---|---|---|
| 7–9 | Strong | Green | Robust, improving fundamentals |
| 4–6 | Moderate | Orange | Mixed signals — investigate further |
| 0–3 | Weak | Red | Deteriorating financials — high risk |
This metric answers the most fundamental question in investing: Is this company creating or destroying value?
| Spread | Status | Color | What It Means |
|---|---|---|---|
| > 5% | Creating Value | Green | Every dollar invested generates returns well above the hurdle rate |
| 0% – 5% | Moderate | Orange | Generating returns close to the cost of capital |
| < 0% | Destroying Value | Red | Growth is actually harmful — the company is selling dollars for 90 cents |
Amazon (AMZN) — Analyst Outlook (Strong Buy, $279.59 target, +40.6% upside) and Ownership panel (65% Institutional, 9% Insider, 0.74% Short Interest)
A gear icon in the Quick Analysis header opens a settings panel with three strictness presets:
| Preset | Revenue CAGR | ROE Min | D/E Max | Current Ratio |
|---|---|---|---|---|
| Conservative | ≥20% | ≥20% | ≤0.5 | ≥2.0 |
| Moderate (Default) | ≥15% | ≥15% | ≤1.0 | ≥1.5 |
| Aggressive | ≥10% | ≥12% | ≤1.5 | ≥1.2 |
Individual thresholds can also be customized per metric. All settings are saved to localStorage.
The Calculated Ratios tab is where you dissect the mechanics of a company’s returns. The headline feature is the DuPont Analysis, followed by a comprehensive display of 40+ financial ratios organized into categories.
Live example: ServiceNow (NOW) — Solvency, Profitability, and Efficiency ratios with color-coded badges (Excellent, Good, Average, Poor)
ServiceNow (NOW) — DuPont Analysis: NPM 13.2% × Asset Turnover 0.51x × Equity Multiplier 2.01x = 13.5% Calculated ROE (vs. 15.5% actual)
The DuPont Analysis breaks Return on Equity into three component levers:
Net Profit Margin × Asset Turnover × Equity Multiplier = ROE
| Component | Formula | What It Reveals |
|---|---|---|
| Net Profit Margin | Net Profit / Revenue | Pricing Power: High margins indicate competitive advantage and sustainable profitability (e.g., Microsoft at ~35%) |
| Asset Turnover | Revenue / Total Assets | Operational Efficiency: How fast the company turns its assets into revenue (e.g., Costco at ~3.5x) |
| Equity Multiplier | Total Assets / Shareholders’ Equity | Financial Leverage: How much debt amplifies returns—higher is riskier (e.g., a highly leveraged company at 5x+) |
The extension displays each component with color-coded ratings and shows a “Three Pillars of ROE” visualization comparing Profitability (margin-driven), Efficiency (turnover-driven), and Leverage (debt-driven).
Below the DuPont section, ratios are organized into categories with color-coded badges (green for Excellent, yellow for Average, red for Poor—all adjusted for the detected sector):
PE Ratio, Forward PE, Price/Sales, Price/Book, Price/FCF, PEG Ratio
EV/Earnings, EV/Sales, EV/EBITDA, EV/EBIT, EV/FCF
Current Ratio, Quick Ratio, Debt/Equity, Debt/EBITDA, Debt/FCF, Interest Coverage
ROE, ROA, ROIC, ROCE, WACC, Asset Turnover, Inventory Turnover
Gross Margin, Operating Margin, Profit Margin, EBITDA Margin, FCF Margin
Dividend Yield, Dividend Growth, Payout Ratio, Buyback Yield, Years of Dividend Growth
Beta (5Y), 52-Week Price Change, 50-Day SMA, 200-Day SMA, RSI, Short % of Float, Short Ratio
Price Target, Price Target Upside %, Analyst Consensus, Analyst Count, Revenue Growth Forecast (5Y), EPS Growth Forecast (5Y)
Altman Z-Score, Piotroski F-Score
Shares Outstanding, Insider Ownership %, Institutional Ownership %
Each ratio is displayed in a compact table format with the label, value, and a color-coded background. Null or unavailable values display as “N/A”. Units are preserved: $ for dollar amounts, % for percentages, x for multiples.
The Price Analysis tab answers a deceptively simple question: Is the current stock price justified by the company’s fundamental growth? A stock can have excellent fundamentals but still be a bad investment if the price has already run far ahead of earnings.
Live example: Meta Platforms (META) — Price vs Fundamentals and Cyclical Analysis overview
The extension compares Stock Price CAGR against Sales CAGR and Profit CAGR over 3-year and 5-year periods:
| Scenario | Signal | Verdict Tag |
|---|---|---|
| Stock Price CAGR >> Profit CAGR | Valuation Expansion — price has outrun fundamentals. Potentially overvalued. | Valuation Expansion |
| Stock Price CAGR ≈ Profit CAGR | Fair Pricing — price and fundamentals are moving in lockstep. | Fair Pricing |
| Profit CAGR >> Stock Price CAGR | Valuation Compression — fundamentals outpacing price. Potentially undervalued. | Catching Up |
A Price/Profit Growth Ratio quantifies this relationship. A ratio below 1.0 suggests the stock may be undervalued relative to its growth; above 1.0 suggests the price has gotten ahead.
Meta (META) — Price/Profit CAGR comparison, Risk Metrics (Mid Range, 19.4% drawdown), and Market Position (Beta 1.28, RSI 42.7, Death Cross at 50/200 DMA)
Measures how much the stock moves relative to the S&P 500:
Total percentage price change over the past year, providing context for whether the stock is in an uptrend or downtrend.
The Valuation tab is the final piece of the puzzle. It compares the company’s current valuation multiples against their own 5-year historical medians, weighted by sector relevance, to produce a clear verdict: Undervalued, Fairly Valued, or Overvalued.
Live example: Applied Materials (AMAT) — “Premium Priced” verdict with all 4 multiples above their 5-year medians. Note the Forward PE annotation (29.5) and sector-aware weight tags (Primary, Important, Supplementary).
Each card displays:
| Metric | What It Measures | Best For |
|---|---|---|
| PE Ratio | Price relative to earnings | Stable earners (FMCG, IT Services) |
| EV/EBITDA | Enterprise value relative to operating profit | Capital-intensive sectors (Energy, Infrastructure, Industrials) |
| Price/Book | Price relative to book value | Asset-heavy sectors (Banking, NBFC, Metals) |
| Price/Sales | Market cap relative to revenue | High-growth companies (Tech, Retail) |
| PEG Ratio | PE normalized by growth rate | Comparing growth stocks fairly |
AMAT — PEG Ratio 3.33 (Overvalued) and Detailed Comparison table showing Current vs. Median with % deviation, status, and sector relevance weights (Primary, Important, Supplementary)
Not all metrics are equally relevant for every sector. The extension assigns relevance weights (0–3) to each valuation metric per sector profile:
| Weight | Significance | In Verdict Calculation |
|---|---|---|
| 3 (Primary) | THE metric for this sector | Highest influence on final verdict |
| 2 (Important) | Standard complementary metric | Strong influence |
| 1 (Supplementary) | Provides context only | Minimal influence |
| 0 (Not Key Metric) | Irrelevant for this sector | Excluded entirely; shown dimmed in UI |
| Sector | PE | EV/EBITDA | P/B | P/Sales | Primary Metric |
|---|---|---|---|---|---|
| Banking | 1 | 0 | 3 | 0 | P/B (banks trade on equity base) |
| NBFC / Finance | 1 | 0 | 3 | 0 | P/B |
| IT / Technology | 3 | 2 | 1 | 2 | PE (profitability + growth focus) |
| Pharma / Healthcare | 3 | 2 | 0 | 2 | PE and EV/EBITDA |
| FMCG / Consumer Staples | 3 | 2 | 0 | 2 | PE (stable, predictable earnings) |
| Energy | 0 | 3 | 1 | 1 | EV/EBITDA (PE is useless for cyclicals) |
| Metals / Mining | 0 | 3 | 2 | 0 | EV/EBITDA (cyclical earnings) |
| Infrastructure | 2 | 3 | 1 | 0 | EV/EBITDA (capital-intensive) |
| Telecom | 0 | 3 | 0 | 0 | EV/EBITDA (dominant metric) |
| Manufacturing / Auto | 3 | 2 | 1 | 1 | PE |
| Retail | 3 | 2 | 0 | 2 | PE (with Price/Sales context) |
| Chemicals | 3 | 2 | 1 | 0 | PE |
The PEG Ratio normalizes PE by the company’s profit growth rate, making it possible to compare high-growth and slow-growth stocks fairly.
Formula: PEG = Trailing PE / 5-Year Profit CAGR (with 3-year fallback)
| PEG Range | Interpretation |
|---|---|
| < 0.5 | Deeply Undervalued — growth is severely discounted |
| 0.5 – 1.0 | Undervalued — attractive entry point |
| 1.0 – 1.5 | GARP Zone — Growth at a Reasonable Price |
| 1.5 – 2.0 | Getting Expensive — premium is being paid |
| > 2.0 | Overvalued — price has outrun growth |
For US stocks, the PE card includes a Forward PE annotation based on analyst estimates for the next 12 months. This provides critical context:
Metrics with weight 0 are shown dimmed with a “Not Key Metric” tag—visible for context but excluded from the verdict.
With all five tabs understood, here is how to perform a complete stock analysis in under five minutes:
Goal: Visualize fundamental trends.
Select the Golden Quartet: Revenue, Operating Margin, Net Income, Free Cash Flow. Look for:
Goal: Instant health check.
Goal: Understand what drives ROE.
Focus on DuPont Analysis: Which lever drives returns?
Goal: Is the price justified?
Goal: Historical context.
| Fundamentals | Valuation | Market Position | Decision |
|---|---|---|---|
| Strong | Cheap | Uptrend | Strong Buy |
| Strong | Cheap | Downtrend | Accumulate (wait for reversal) |
| Strong | Fair | Uptrend | Hold / Buy |
| Strong | Expensive | Overbought | Trim (take partial profits) |
| Weak | Cheap | Downtrend | Avoid (value trap) |
| Weak | Expensive | Uptrend | Avoid |
| Mixed | Fair | Neutral | Research More |
| Issue | Possible Cause | Fix |
|---|---|---|
| “Visualize” button does not appear | Not on a stock page, extension disabled, or page still loading | Navigate to stockanalysis.com/stocks/aapl/. Check chrome://extensions/. Refresh the page. |
| Button appears slowly (3–8 seconds) | Phase 1 data fetch in progress | Normal behavior. The button appears after core data loads. |
| Chart is empty after selecting metrics | Paywalled data or browser cache issue | Click “Reset Preferences”. Reload the extension. |
| Quick Analysis shows incomplete data | Phase 2 (Statistics/History) still loading | Wait 1–3 seconds. Tabs auto-refresh when enrichment completes. |
| Panel shows old stock after navigating | SPA navigation not detected | Refresh the page (Cmd+R or Ctrl+R). |
| TradingView opens wrong symbol | Symbol extraction conflict | Verify the stock ticker in the URL matches what you expect. |
| Scrolling does not work in panel | Wheel events not forwarding | Use the scroll buttons inside the panel, or try scrolling directly on the tab content area. |
Yes. 100% free forever. No trial, no premium tier, no hidden costs, no account creation required.
No. The extension runs entirely client-side. It never sends data to external servers, does not track which stocks you research, and does not build a profile of your browsing history.
No. Chrome extensions only work on desktop browsers. However, you can take screenshots of charts for mobile-friendly sharing.
The extension extracts data directly from stockanalysis.com’s HTML tables. It is exactly as accurate as the source data. The extension does not estimate, impute, or modify any financial figures.
Yes. The extension supports three platforms: stockanalysis.com (US stocks), Screener.in (Indian stocks), and Google Finance (limited). This tutorial focuses on the US stock experience, which has the most features.
stockanalysis.com locks some historical data behind a paywall. The extension detects columns with “Upgrade” text and filters them out, which may reduce the number of years displayed.
Yes. Click the gear icon in the Quick Analysis tab header to choose between Conservative, Moderate, and Aggressive presets, or customize individual thresholds.
You now have a complete understanding of every tab, every button, every metric, and every sector-specific strategy in the Finmagine Chrome Extension for US stocks. What used to require a Bloomberg terminal, a CFA charter, and 30 minutes per stock now takes a single browser extension and five minutes.
What you have mastered:
Next Steps:
Explore more tools and resources at Finmagine.com—where financial analysis becomes effortless.
Discover all Chart Builder resources—tutorials for Indian stocks, US stocks, Google Finance integration, case studies, and more.
Visit Chart Builder Hub →